Board to review September 2026 quarterly and half-year results

Results View source PDF Explain this filing

IOLCP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.8%Reaction day

₹170.80

prior close

₹164.39

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.3%-0.5% vs market

Pharmaceuticals peers, median of 170sector-1.5%-1.3% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 1.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-0.7

15m

-0.6

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.8-2.3-0.5-1.5-1.3

Next day

-1.6-1.9+0.3-0.4-1.2

+5.7-0.2+5.9+1.5+4.2

+5.5pendingpending+2.5+3.0

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board will meet on 30 October 2026 to approve unaudited financial results for the quarter and six months ended 30 September 2026. The trading window has been closed since 1 October and is scheduled to reopen on 2 November.

Likely market impact

No financial figures were disclosed. Shareholders will need to wait for the 30 October results to assess performance and possible price movement.